Rennova Health, Inc. (RNVA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 49.66 Million USD | 5.82% |
| 2021 | 46.93 Million USD | -23.41% |
| 2020 | 61.27 Million USD | -32.83% |
| 2019 | 91.22 Million USD | 70.94% |
| 2018 | 53.36 Million USD | 13.78% |
| 2017 | 46.9 Million USD | 119.5% |
| 2016 | 21.36 Million USD | -26.73% |
| 2015 | 29.16 Million USD | 1998.25% |
| 2014 | 1.39 Million USD | -91.6% |
| 2013 | 16.53 Million USD | 1194.12% |
| 2012 | 1.27 Million USD | 119.59% |
| 2011 | 582 Thousand USD | -67.52% |
| 2010 | 1.79 Million USD | -58.96% |
| 2009 | 4.36 Million USD | 1.39% |
| 2008 | 4.3 Million USD | -39.77% |
| 2007 | 7.14 Million USD | -73.75% |
| 2006 | 27.23 Million USD | 399.71% |
| 2005 | 5.45 Million USD | -19.74% |
| 2004 | 6.79 Million USD | -11.83% |
| 2003 | 7.7 Million USD | 26.57% |
| 2002 | 6.08 Million USD | -12.32% |
| 2001 | 6.94 Million USD | -49.12% |
| 2000 | 13.64 Million USD | 67.56% |
| 1999 | 8.14 Million USD | -8.52% |
| 1998 | 8.9 Million USD | -13.59% |
| 1997 | 10.3 Million USD | -20.77% |
| 1996 | 13 Million USD | -19.75% |
| 1995 | 16.2 Million USD | -31.36% |
| 1994 | 23.6 Million USD | 38.01% |
| 1993 | 17.1 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 48.56 Million USD | -0.6% |
| 2023 Q1 | 48.86 Million USD | -1.62% |
| 2023 Q3 | 47.41 Million USD | -2.38% |
| 2022 Q2 | 47.8 Million USD | 0.46% |
| 2022 Q1 | 47.58 Million USD | 1.38% |
| 2022 Q4 | 49.66 Million USD | -1.07% |
| 2022 Q3 | 50.2 Million USD | 5.02% |
| 2022 FY | 49.66 Million USD | 5.82% |
| 2021 Q2 | 60.96 Million USD | -4.93% |
| 2021 Q4 | 46.93 Million USD | -19.09% |
| 2021 FY | 46.93 Million USD | -23.41% |
| 2021 Q1 | 64.12 Million USD | 4.64% |
| 2021 Q3 | 58 Million USD | -4.85% |
| 2020 Q2 | 76.53 Million USD | -21.95% |
| 2020 Q1 | 98.05 Million USD | 7.48% |
| 2020 Q3 | 55.63 Million USD | -27.31% |
| 2020 Q4 | 61.27 Million USD | 10.15% |
| 2020 FY | 61.27 Million USD | -32.83% |
| 2019 Q2 | 72.57 Million USD | 14.27% |
| 2019 Q1 | 63.51 Million USD | 19.01% |
| 2019 FY | 91.22 Million USD | 70.94% |
| 2019 Q4 | 91.22 Million USD | 8.3% |
| 2019 Q3 | 84.23 Million USD | 16.07% |
| 2018 Q4 | 53.36 Million USD | 7.67% |
| 2018 FY | 53.36 Million USD | 13.78% |
| 2018 Q2 | 146.19 Million USD | -23.08% |
| 2018 Q1 | 190.04 Million USD | 305.18% |
| 2018 Q3 | 49.56 Million USD | -66.09% |
| 2017 Q2 | 23.2 Million USD | -68.49% |
| 2017 Q1 | 73.64 Million USD | 244.65% |
| 2017 FY | 46.9 Million USD | 119.5% |
| 2017 Q4 | 46.9 Million USD | 86.47% |
| 2017 Q3 | 25.15 Million USD | 8.41% |
| 2016 Q3 | 20.23 Million USD | -30.91% |
| 2016 Q1 | 27.89 Million USD | -8.72% |
| 2016 Q2 | 29.28 Million USD | 4.99% |
| 2016 FY | 21.36 Million USD | -26.73% |
| 2016 Q4 | 21.36 Million USD | 5.6% |
| 2015 Q3 | 936 Thousand USD | -30.92% |
| 2015 FY | 29.16 Million USD | 1998.25% |
| 2015 Q2 | 1.35 Million USD | -1.31% |
| 2015 Q1 | 1.37 Million USD | -0.36% |
| 2015 Q4 | 30.56 Million USD | 3165.36% |
| 2014 Q4 | 1.37 Million USD | 2.07% |
| 2014 FY | 1.39 Million USD | -91.6% |
| 2014 Q1 | 1.39 Million USD | -0.79% |
| 2014 Q3 | 1.35 Million USD | -17.48% |
| 2014 Q2 | 1.63 Million USD | 17.7% |
| 2013 Q4 | 1.4 Million USD | 4.32% |
| 2013 Q3 | 1.34 Million USD | 3.87% |
| 2013 Q2 | 1.29 Million USD | 1.17% |
| 2013 Q1 | 1.27 Million USD | -12.23% |
| 2013 FY | 16.53 Million USD | 1194.12% |
| 2012 Q2 | 439 Thousand USD | -24.57% |
| 2012 Q3 | 1.65 Million USD | 276.08% |
| 2012 Q4 | 1.45 Million USD | -11.81% |
| 2012 FY | 1.27 Million USD | 119.59% |
| 2012 Q1 | 582 Thousand USD | 8.18% |
| 2011 Q2 | 1.29 Million USD | -27.73% |
| 2011 FY | 582 Thousand USD | -67.52% |
| 2011 Q4 | 538 Thousand USD | -40.49% |
| 2011 Q3 | 904 Thousand USD | -30.19% |
| 2011 Q1 | 1.79 Million USD | -44.55% |
| 2010 FY | 1.79 Million USD | -58.96% |
| 2010 Q2 | 2.96 Million USD | -32.04% |
| 2010 Q1 | 4.36 Million USD | -17.82% |
| 2010 Q4 | 3.23 Million USD | 77.48% |
| 2010 Q3 | 1.82 Million USD | -38.62% |
| 2009 Q1 | 4.3 Million USD | -21.16% |
| 2009 FY | 4.36 Million USD | 1.39% |
| 2009 Q2 | 4.66 Million USD | 8.24% |
| 2009 Q3 | 4.43 Million USD | -4.87% |
| 2009 Q4 | 5.31 Million USD | 19.82% |
| 2008 Q4 | 5.46 Million USD | 44.46% |
| 2008 Q2 | 5.66 Million USD | -20.7% |
| 2008 Q1 | 7.14 Million USD | -73.45% |
| 2008 Q3 | 3.78 Million USD | -33.3% |
| 2008 FY | 4.3 Million USD | -39.77% |
| 2007 FY | 7.14 Million USD | -73.75% |
| 2007 Q1 | 27.23 Million USD | 7.4% |
| 2007 Q2 | 28.6 Million USD | 5.03% |
| 2007 Q3 | 28.19 Million USD | -1.45% |
| 2007 Q4 | 26.92 Million USD | -4.51% |
| 2006 Q3 | 5.62 Million USD | -10.84% |
| 2006 Q1 | 5.45 Million USD | -23.7% |
| 2006 FY | 27.23 Million USD | 399.71% |
| 2006 Q2 | 6.31 Million USD | 15.78% |
| 2006 Q4 | 25.36 Million USD | 350.74% |
| 2005 Q2 | 6.5 Million USD | -4.26% |
| 2005 Q4 | 7.14 Million USD | -45.5% |
| 2005 Q1 | 6.79 Million USD | -15.76% |
| 2005 FY | 5.45 Million USD | -19.74% |
| 2005 Q3 | 13.1 Million USD | 101.58% |
| 2004 Q4 | 8.06 Million USD | 6.96% |
| 2004 Q2 | 5.38 Million USD | -30.07% |
| 2004 FY | 6.79 Million USD | -11.83% |
| 2004 Q1 | 7.7 Million USD | 15.78% |
| 2004 Q3 | 7.53 Million USD | 39.93% |
| 2003 Q1 | 6.08 Million USD | -11.68% |
| 2003 Q3 | 7.72 Million USD | -0.77% |
| 2003 FY | 7.7 Million USD | 26.57% |
| 2003 Q4 | 6.65 Million USD | -13.82% |
| 2003 Q2 | 7.78 Million USD | 27.83% |
| 2002 Q4 | 6.89 Million USD | -20.43% |
| 2002 Q1 | 6.94 Million USD | -41.14% |
| 2002 Q2 | 5.8 Million USD | -16.34% |
| 2002 FY | 6.08 Million USD | -12.32% |
| 2002 Q3 | 8.66 Million USD | 49.13% |
| 2001 Q4 | 11.79 Million USD | -19.89% |
| 2001 Q1 | 13.64 Million USD | 7.31% |
| 2001 Q2 | 16.89 Million USD | 23.83% |
| 2001 FY | 6.94 Million USD | -49.12% |
| 2001 Q3 | 14.71 Million USD | -12.87% |
| 2000 FY | 13.64 Million USD | 67.56% |
| 2000 Q3 | 13.74 Million USD | 16.62% |
| 2000 Q4 | 12.71 Million USD | -7.5% |
| 2000 Q2 | 11.78 Million USD | 44.76% |
| 2000 Q1 | 8.14 Million USD | -46.78% |
| 1999 FY | 8.14 Million USD | -8.52% |
| 1999 Q2 | 9.8 Million USD | 10.11% |
| 1999 Q3 | 12 Million USD | 22.45% |
| 1999 Q4 | 15.3 Million USD | 27.5% |
| 1999 Q1 | 8.9 Million USD | -16.82% |
| 1998 Q2 | 9.4 Million USD | -8.74% |
| 1998 Q4 | 10.7 Million USD | -1.83% |
| 1998 FY | 8.9 Million USD | -13.59% |
| 1998 Q1 | 10.3 Million USD | -6.36% |
| 1998 Q3 | 10.9 Million USD | 15.96% |
| 1997 FY | 10.3 Million USD | -20.77% |
| 1997 Q4 | 11 Million USD | -10.57% |
| 1997 Q1 | 13 Million USD | 38.3% |
| 1997 Q3 | 12.3 Million USD | 0.82% |
| 1997 Q2 | 12.2 Million USD | -6.15% |
| 1996 Q3 | 16.4 Million USD | 1.86% |
| 1996 Q4 | 9.4 Million USD | -42.68% |
| 1996 FY | 13 Million USD | -19.75% |
| 1996 Q1 | 16.2 Million USD | -2.99% |
| 1996 Q2 | 16.1 Million USD | -0.62% |
| 1995 Q4 | 16.7 Million USD | -41.97% |
| 1995 FY | 16.2 Million USD | -31.36% |
| 1995 Q3 | 28.78 Million USD | 18.29% |
| 1995 Q1 | 23.6 Million USD | 0.0% |
| 1995 Q2 | 24.33 Million USD | 3.09% |
| 1994 FY | 23.6 Million USD | 38.01% |
| 1993 FY | 17.1 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -1276.59% |
| Arrayit Corporation | 7.49 Million USD | -562.532% |
| Atlantic International Corp. | 3.82 Million USD | -1197.266% |
| Biocept, Inc. | 22.01 Million USD | -125.627% |
| Bioqual, Inc. | 18.93 Million USD | -162.263% |
| CardioGenics Holdings Inc | 1.79 Million USD | -2667.102% |
| DermTech, Inc. | 64.75 Million USD | 23.3% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 93.242% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -300.997% |
| iMD Companies, Inc. | 1.67 Million USD | -2866.603% |
| IDenta Corp. | 1.01 Million USD | -4802.231% |
| Interpace Biosciences, Inc. | 28.15 Million USD | -76.394% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -16569.861% |
| InVitro International | 78.99 Thousand USD | -62778.023% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | -151.748% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -38313.382% |
| Medical Imaging Corp. | 9.51 Million USD | -421.876% |
| NovelStem International Corp. | 4.2 Million USD | -1080.847% |
| Optigenex Inc. | 9.57 Million USD | -418.957% |
| PharmChem, Inc. | 558.64 Thousand USD | -8790.65% |
| Proteome Sciences plc | 18.48 Million USD | -168.631% |
| Response Genetics, Inc | 15.86 Million USD | -213.023% |
| RushNet, Inc. | 6.23 Million USD | -696.08% |
| ScreenPro Security Inc. | 1.6 Million USD | -3003.071% |
| Stella Diagnostics Inc. | 18 Million USD | -175.847% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -505.405% |
| Todos Medical Ltd. | 50.15 Million USD | 0.976% |